Fortis Healthcare share price
NSE: FORTISBSE: 532843Healthcare ServicesMid Cap
Formerly Fortis Healthcare (India)
Last close ₹712.90down ₹13.75 (1.89%)BSE ₹720.00
Share price at the NSE close on 23 Oct 2026. Previous close ₹726.65.
52-week range of traded prices to 23 Oct 2026
₹704.95Low, 23 Oct 2026₹1,104.00High, 23 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹53,821 Cr156th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 6 Aug 2026
- 51.4
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 22 May 2026
- 5.4
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.14%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 6 Aug 2026
- 11.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 6 Aug 2026
- 12.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 22 May 2026
- 0.28
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 9,87,09051.8% delivered
Results
Consolidated; ₹ crore, the charts by years to March, the table by quarter.Quarterly results
Quarter to Jun 2026, against the quarter beforeFiled 6 Aug
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹2,545 Crup 7.63%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹273 Crup 0.59%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 10.7%
Revenue by year
Peak revenue ₹9,128 Cr, year to Mar 2026
Net profit by year, a loss in red
- Net profit
- Loss
A loss in 3 of the 10 years shown
| ₹ crore | Sep 2024Filed 8 Nov | Dec 2024Filed 7 Feb | Mar 2025Filed 12 Jun | Jun 2025Filed 6 Aug | Sep 2025Filed 11 Nov | Dec 2025Filed 13 Feb | Mar 2026Filed 22 May | Jun 2026Filed 6 Aug |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,988 | 1,928 | 2,007 | 2,167 | 2,331 | 2,265 | 2,365 | 2,545 |
| Net profit | 193 | 254 | 188 | 267 | 329 | 197 | 271 | 273 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 9.7% | 13.2% | 9.4% | 12.3% | 14.1% | 8.7% | 11.5% | 10.7% |
Consolidated. The last eight quarters. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
Share of revenue, year to Mar 2026, consolidated.Segment revenue and profit
- HealthcareHealthcare, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹7,773 Crup 19.07%83.6%
- DiagnosticsDiagnostics, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹1,527 Crup 8.52%16.4%
The pill is the change in revenue on the year before; the share is of all the businesses together.
Valuation
Today, against the company's own history.PE ratio and valuation history
Price to earningsPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
At or below today's level on 23% of 1,240 trading days over the last 5 years.
LowestHighest
Its median64.7Industry median40.5
Price to bookPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
At or below today's level on 72% of 1,890 trading days since Nov 2018.
LowestHighest
Its median3.4Industry median4.6
EV to EBITDAEnterprise value to EBITDA. Market cap plus borrowings less cash and bank balances, divided by operating profit before depreciation (revenue less operating expenses, without other income and one-off items) over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly): what the whole business costs against the profit its operations make. Lease liabilities are not counted: the results filings do not state them.26.3
At or below today's level on 39% of 1,839 trading days since May 2019.
LowestHighest
Its median29.2Industry median22.3
Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price. When a year's dividend goes ex later than the year before's, the yield reads zero for the days between; a run of under 60 such trading days is left out of the yield's medians and percentiles. The ex-date is the day from which a buyer of the share no longer gets the dividend.
At or below today's level on 82% of 2,476 trading days over the last 10 years.
LowestHighest
Its median0.00%Industry median0.26%
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +14.0% | +34.5% | −15.4% | 0.1% |
| 3 years | +45.3% | +20.9% | +20.0% | 0.2% |
| 5 years | +32.1% | – | – | 0.2% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record. Earnings growth over 1 and 3 years includes one-off items (exceptional items and the result of businesses sold or closed) of more than a tenth of the profit of the years to Mar 2023 and Mar 2025.
Mutual funds holding it
271 funds disclosed a holding for Sep 2026. What they did in Sep 2026, against each fund's month before. 107 of the 148 funds that added or cut are index funds, ETFs or arbitrage funds: an index fund or ETF holds what its index holds, and an arbitrage fund holds the share against a sale of its future. 1 more fund filed its first portfolio on record, holding it.Mutual fund holdings
- Bought for the first timeBought for the first time. Funds that held it at the month's end and had not held it in any month on record before.
- 10
- Bought againBought again. Funds that held it at the month's end, had not held it the month before, and held it in an earlier month.
- 2
- AddedAdded. Funds that held more shares than at the end of the month before.
- 73
- CutCut. Funds that held fewer shares than at the end of the month before.
- 75
- Held unchangedHeld unchanged. Funds that held the same number of shares as at the end of the month before.
- 110
- Sold outSold out. Funds that held it at the end of the month before and hold none at this month's end.
- 16
| Fund | |||
|---|---|---|---|
 HDFC Mid Cap FundHDFC Mutual Fund | 3,17,01,862 | 2.40% | ₹2,441.0 Cr |
 Kotak Mid Cap FundKotak Mahindra Mutual Fund | 3,01,61,426 | 3.49% | ₹2,322.4 Cr |
 Nippon India Growth Mid Cap FundNippon India Mutual Fund | 1,65,00,100 | 2.53% | ₹1,270.5 Cr |
 Axis Midcap FundAxis Mutual Fund | 1,13,75,762 | 2.61% | ₹875.9 Cr |
 DSP Midcap FundDSP Mutual Fund | 63,94,812 | 2.53% | ₹492.4 Cr |
| HDFC Small Cap FundHDFC Mutual Fund | 50,00,176 | 0.94% | ₹385.0 Cr |
| HDFC Large & Mid Cap FundHDFC Mutual Fund | 47,33,349 | 1.28% | ₹364.5 Cr |
| Kotak Large & Mid Cap FundKotak Mahindra Mutual Fund | 47,00,000 | 1.18% | ₹361.9 Cr |
 Edelweiss Mid Cap FundEdelweiss Mutual Fund | 41,81,418 | 1.67% | ₹322.0 Cr |
| DSP Large & Mid Cap FundDSP Mutual Fund | 35,72,023 | 1.59% | ₹275.0 Cr |
Portfolios disclosed for Sep 2026. Weight is the holding as a share of the fund's assets.
Peers and competitors
Hospital, 38 listed companies, priced on 23 Oct 2026. The table lists the 8 companies closest to Fortis Healthcare in market cap.
Where the company sits among the companies nearest its size
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
 Apollo Hospitals EnterpriseAPOLLOHOSP | 1,11,146 | 53.2 | 11.7 | 28.9 | +17.2% | +32.8% | 23.6% | 19.9% | 0.26% |
| Manipal Health EnterprisesMANIPALHOS | 79,889 | – | – | – | – | – | – | – | 0.00% |
 Max Healthcare InstituteMAXHEALTH | 79,325 | 54.4 | 7.4 | 35.4 | +16.0% | +27.0% | 14.5% | 13.0% | 0.25% |
 Aster DM Quality CareASTERDM | 56,201 | 176.4 | – | – | +15.7% | +0.2% | 8.0% | 12.4% | 0.47% |
 Narayana HrudayalayaNH | 33,656 | 41.2 | 7.4 | 20.8 | +57.8% | +3.9% | 20.0% | 13.1% | 0.27% |
 Global HealthMEDANTA | 31,862 | 57.3 | 8.0 | 32.6 | +21.3% | +4.1% | 15.1% | 14.2% | 0.04% |
 Krishna Institute of Medical SciencesKIMS | 27,937 | 136.6 | 12.4 | 37.4 | +30.9% | −46.2% | 9.3% | 8.7% | 0.00% |
 Dr. Agarwal's Health CareAGARWALEYE | 15,024 | 101.3 | 7.4 | 24.6 | – | – | 7.6% | 14.1% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Dividends
Per share, by the year it was paid for, and the latest payments.Dividend history and dates
Dividend per share, ₹, restated for later splits and bonuses
Dividend per share. The dividends declared for the year, each restated to today's share count by the splits and bonuses after its own ex-date, added up.Highest ₹1.00 a share, in 4 years, the latest the year to Mar 2026.
| Ex-date | Type | Per share |
|---|---|---|
| 24 Jul 2026 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹1.00 |
| 25 Jul 2025 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹1.00 |
| 24 Jul 2024 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹1.00 |
| 20 Jul 2023 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹1.00 |
Latest payments, as declared, by ex-date.
Latest announcements
Routine notices left out.Share news and announcements
Oct 2026
Sep 2026
Fortis Healthcare share price by year
Each calendar year to 2025.Fortis Healthcare share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 884.00 | +22.8% | 1,097.90 | 581.20 |
| 2024 | 719.85 | +71.7% | 725.80 | 380.80 |
| 2023 | 419.20 | +46.5% | 419.20 | 250.60 |
| 2022 | 286.10 | −3.8% | 321.05 | 226.05 |
| 2021 | 297.30 | +91.6% | 297.30 | 155.75 |
| 2020 | 155.20 | +17.7% | 164.45 | 113.50 |
| 2019 | 131.90 | −6.1% | 158.60 | 116.25 |
| 2018 | 140.50 | −12.4% | 165.60 | 114.20 |
| 2017 | 160.45 | −11.3% | 226.80 | 125.10 |
| 2016 | 180.85 | +0.4% | 193.80 | 150.40 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before.
Recent sessions
The last 10 trading days to 23 Oct 2026, as traded on NSE.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 23 Oct 2026 | 726.65 | 728.65 | 704.95 | 712.90 | 712.60 | 9,87,090 | 51.8% |
| 22 Oct 2026 | 723.50 | 726.65 | 710.80 | 726.65 | 720.78 | 12,61,211 | 61.2% |
| 21 Oct 2026 | 735.00 | 741.55 | 721.00 | 729.00 | 729.26 | 7,03,314 | 52.0% |
| 19 Oct 2026 | 737.25 | 745.15 | 731.80 | 737.80 | 739.97 | 10,76,545 | 61.7% |
| 16 Oct 2026 | 749.00 | 749.00 | 734.15 | 736.50 | 739.28 | 11,41,924 | 59.4% |
| 15 Oct 2026 | 746.50 | 758.95 | 740.20 | 746.25 | 750.09 | 21,91,136 | 54.8% |
| 14 Oct 2026 | 758.90 | 758.90 | 737.95 | 750.00 | 746.98 | 21,91,923 | 55.5% |
| 13 Oct 2026 | 757.00 | 767.70 | 745.20 | 756.40 | 753.42 | 20,90,170 | 55.7% |
| 12 Oct 2026 | 781.10 | 785.55 | 755.00 | 757.25 | 772.55 | 9,98,167 | 47.1% |
| 9 Oct 2026 | 788.00 | 806.00 | 778.00 | 786.25 | 789.96 | 36,38,882 | 24.9% |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Open offer history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 18 Aug 2009 | Rights issue | – | Shareholders were offered new shares. Noted, not adjusted for. |
Each event is noted and not adjusted for.
About Fortis Healthcare
Fortis Healthcare Limited provides healthcare services and runs multi-specialty hospitals. It has 36 healthcare facilities across India and more than 28,500 employees, a count that includes its diagnostics arm. Its hospitals focus on oncology, neurosciences, cardiac sciences, gastroenterology, orthopaedics and renal sciences.
The business has two parts, hospitals and diagnostics, and each is reviewed on its own.The diagnostics business is run by Agilus Diagnostics. The hospitals are grouped in clusters in NCR, Punjab, Bengaluru, Kolkata and Mumbai. Some are run under operations and management (O&M) arrangements. Fortis has an O&M services agreement with Gleneagles Healthcare India to manage about 700 beds across five hospitals and one clinic. It also runs Adayu, a 36-bed mental healthcare facility in Gurugram, and has signed a 15-year lease with RR Lifesciences for a hospital in Greater Noida.
Fortis was incorporated in 1996. Its recent additions include the 228-bed Shrimann Superspecialty Hospital in Jalandhar, whose acquisition was completed in July 2025. Through a wholly owned subsidiary, it also acquired the 125-bed People Tree Hospital in Bengaluru.
Its promoter is Northern TK Ventures Pte. Ltd. A promoter is the person or group that set up a company or controls it. Northern TK Ventures is a wholly owned subsidiary of IHH Healthcare Berhad of Malaysia, which acquired a stake in Fortis along with a majority on its board in November 2018.
- Legal name
- Fortis Healthcare Limited
- NSE symbol
- FORTIS
- BSE code
- 532843
- ISIN
- INE061F01013
- Industry
- Healthcare Services
- Listed
- May 2007
- Face value
- ₹10
- CIN
- L85110PB1996PLC045933
- Corporate identity number, the registrar of companies' code for it
In Nifty 200, BSE 200, Nifty 500, BSE 500, Nifty Midcap 150, BSE 150 MidCap Index